{
    "nct_id": "NCT06241456",
    "official_title": "A Phase 1 Study of FT825/ONO-8250, an Off-the-Shelf CAR T-Cell Therapy, with or Without Monoclonal Antibodies, in HER2-Positive or Other Advanced Solid Tumors",
    "inclusion_criteria": "* Histopathological or cytologically confirmed locally advanced or metastatic cancer that meets protocol-defined criteria\n* Disease that is not amenable to curative therapy, with prior therapies defined by specific tumor types\n* Contraceptive use by women and men should be consistent with local regulations regarding the methods of contraception for those participating in clinical studies\n* Eastern Cooperative Oncology Group (ECOG) Performance Status 0 or 1\n* Presence of measurable disease by RECIST, v1.1 assessed within 28 days prior to start of first study intervention\n* Anticipated life expectancy of at least 3 months\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Females who are pregnant or breastfeeding\n* Evidence of inadequate organ function\n* Clinically significant cardiovascular disease\n* Known active central nervous system (CNS) involvement by malignancy\n* Non-malignant CNS disease such as stroke, epilepsy, CNS vasculitis, or neurodegenerative disease or receipt of medications for these conditions within 2 years prior to study enrollment\n* Active bacterial, fungal, or viral infections\n* Prior receipt of chimeric antigen receptor (CAR) T-cell therapy, other cellular therapy, or a FATE investigational human induced pluripotent stem cell (iPSC) product\n* History of (non-infectious) interstitial lung disease (ILD)/pneumonitis that required steroids, current ILD/pneumonitis, or suspected ILD/pneumonitis that cannot be ruled out based on imaging at screening\n* Any history of Grade ≥3 immune-related AE or Grade ≥2 eye toxicity attributed to prior cancer immunotherapy, other than endocrinopathy managed with replacement therapy or asymptomatic elevation of serum amylase or lipase\n* Active or history of autoimmune disease or immune deficiency\n* Receipt of an allograft organ transplant",
    "miscellaneous_criteria": ""
}